<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> as well as those with a lack in the prostacyclin synthesis stimulating plasma factor (PF) are prone to develop <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and are at a higher clinical risk for <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>As patients with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> have been reported to show elevated <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> (Lp)(a) levels, we re-examined <z:hpo ids='HP_0000001'>all</z:hpo> our patients known to have an inborn or an acquired persistent deficiency of PF </plain></SENT>
<SENT sid="2" pm="."><plain>Their non-affected relatives served as controls </plain></SENT>
<SENT sid="3" pm="."><plain>In addition, 36 patients suffering from clinically manifested <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> as well as 16 healthy adults, <z:hpo ids='HP_0000001'>all</z:hpo> of them having elevated Lp(a) levels (&gt; 30 mg/dl), were screened for a PF deficiency </plain></SENT>
<SENT sid="4" pm="."><plain>In fact, <z:hpo ids='HP_0000001'>all</z:hpo> the patients with a deficient PF activity showed elevated Lp(a) values </plain></SENT>
<SENT sid="5" pm="."><plain>While the prevalence of PF deficiency ranges about 1-2%, in 7 (19%) patients with clinically manifested <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and 3 (19%) healthy adults with elevated Lp(a) this defect was found </plain></SENT>
<SENT sid="6" pm="."><plain>The findings demonstrate an association between PF deficiency and Lp(a), indicating a biochemical interaction which needs to be further elucidated </plain></SENT>
</text></document>